Form S-1/A Parabilis Medicines,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260604/A42ZT22EZZ2RP2ZU22JC2WYSHRBDZZ22ZI82
Filed on: June 4, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nth Cycle files draft S-4 for SPAC merger at $585M enterprise value
- Nuvation Bio posts $31.7M Q2 revenue, widens net loss to $62.8M
- iSpecimen prices $5 million public offering at $1.30 per share
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
